Helicos BioSciences (FRA:HB4) Volatility : N/A% (As of Jun. 22, 2024)

View and export this data going back to . Start your Free Trial

What is Helicos BioSciences Volatility?

Volatility is a statistical measure of the dispersion of returns for a given security or market index, it shows how the price swings around its mean. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year. In most cases, the higher the volatility, the riskier the security.

Helicos BioSciences does not have enough data to calculate Volatility.

Competitive Comparison of Helicos BioSciences's Volatility

For the Drug Manufacturers - Specialty & Generic subindustry, Helicos BioSciences's Volatility, along with its competitors' market caps and Volatility data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Helicos BioSciences's Volatility Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Helicos BioSciences's Volatility distribution charts can be found below:

* The bar in red indicates where Helicos BioSciences's Volatility falls into.

Helicos BioSciences (FRA:HB4) Volatility Calculation

The annualized volatility is calculated as following:

σ_A	=	σ_M	*	√12
	=	√ 1/(n-1) ∑(Ri - R')^2	*	√12

Where: σ_M is the monthly volatility, n is the number of months in the period, R_i is the security's historical monthly returns and R' is the arithmetic mean of monthly returns.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Helicos BioSciences (FRA:HB4) Volatility Explanation

Volatility is a statistical measure of the dispersion of returns for a given security or market index. It’s often measured as standard deviation or variance of historical returns over a certain period. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year.

Volatility reflects the uncertainty or risk of a security’s value. Generally speaking, a higher volatility suggests a higher risk, because it implies a wider fluctuation around average price. This means the price of the security can change dramatically in either direction within a short period. Conversely, a lower volatility means that the security's price is more steady, which suggests a lower risk.

Another measurement of relative volatility is Beta. Beta is a measure of systematic risk of a security or a portfolio in comparison to the market as a whole. Beta is usually compared to 1. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Helicos BioSciences Volatility Related Terms

Thank you for viewing the detailed overview of Helicos BioSciences's Volatility provided by GuruFocus.com. Please click on the following links to see related term pages.

Helicos BioSciences (FRA:HB4) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Helicos BioSciences Corp (FRA:HB4) » Definitions » Volatility

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Helicos BioSciences Corp is incorporated in the state of Delaware and was incorporated on May 9, 2003. It is a life sciences company focused on genetic analysis technologies for the research, drug discovery and clinical diagnostics markets. The Company's products are based on its proprietary True Single Molecule Sequencing (tSMS) technology which enables rapid analysis of large quantities of genetic material by directly sequencing single molecules of DNA or single DNA copies of RNA. The Company's Helicos Genetic Analysis Platform is designed to obtain sequencing information by repetitively performing a cycle of biochemical reactions on individual DNA molecules and imaging the results after each cycle. The platform consists of an instrument called the HeliScope Single Molecule Sequencer, an image analysis computer tower called the HeliScope Analysis Engine, associated reagents, which are chemicals used in the sequencing process, and disposable supplies. The Company is subject, both directly and indirectly, to the adverse impact of existing and potential future government regulation of its operations and markets.

Helicos BioSciences (FRA:HB4) Headlines

No Headlines